dihexa autism and Dyslexia Autism & Dyslexia | Rise
Description
Treatment sequencing using the dual amylin and calcitonin receptor agonist KBP-336 and semaglutide results in durable weight loss
JAMA Surg 2017;152:1176-8
Convenient and Quick Injections take only minutes and can easily fit into a busy schedule for ongoing health support
Silicified collagen scaffold induces semaphorin 3A secretion by sensory nerves to improve in-situ bone regeneration
Dihexa's hexanoic acid cap increases its lipophilicity significantly compared to unmodified peptides, making it a strong candidate for sublingual delivery
Sustained endosomal release of a neurokinin-1 receptor antagonist from nanostars provides long-lasting relief of chronic pain
